BlackRock Fund Advisors’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $170M | Buy |
922,913
+191,515
| +26% | +$35.2M | 0.03% | 773 |
|
|
2016
Q3 | $188M | Buy |
731,398
+49,966
| +7% | +$12.9M | 0.04% | 578 |
|
|
2016
Q2 | $145M | Buy |
681,432
+12,800
| +2% | +$2.73M | 0.03% | 699 |
|
|
2016
Q1 | $138M | Buy |
668,632
+11,451
| +2% | +$2.36M | 0.03% | 701 |
|
|
2015
Q4 | $166M | Buy |
657,181
+4,653
| +0.7% | +$1.18M | 0.04% | 587 |
|
|
2015
Q3 | $107M | Buy |
652,528
+33,263
| +5% | +$5.47M | 0.03% | 852 |
|
|
2015
Q2 | $116M | Buy |
619,265
+294,650
| +91% | +$55.3M | 0.03% | 863 |
|
|
2015
Q1 | $53.6M | Buy |
324,615
+9,058
| +3% | +$1.49M | 0.01% | 1467 |
|
|
2014
Q4 | $73.4M | Buy |
315,557
+28,484
| +10% | +$6.62M | 0.02% | 1189 |
|
|
2014
Q3 | $52M | Sell |
287,073
-11,638
| -4% | -$2.11M | 0.01% | 1341 |
|
|
2014
Q2 | $57.4M | Sell |
298,711
-25,527
| -8% | -$4.91M | 0.02% | 1310 |
|
|
2014
Q1 | $58.9M | Buy |
324,238
+35,456
| +12% | +$6.45M | 0.02% | 1292 |
|
|
2013
Q4 | $49.2M | Sell |
288,782
-3,237
| -1% | -$551K | 0.02% | 1410 |
|
|
2013
Q3 | $45.8M | Buy |
292,019
+38,975
| +15% | +$6.11M | 0.02% | 1411 |
|
|
2013
Q2 | $43.8M | Buy |
+253,044
| New | +$43.8M | 0.02% | 1317 |
|